Table 3.
Treatment1 | P-value | |||||
---|---|---|---|---|---|---|
Item2 | CON | GG | SEM | Treatment | Week | Treatment × Week |
TP, g/L | 61.67 | 65.24 | 4.84 | 0.107 | <0.001 | 0.900 |
BHBA, mM | 0.31 | 0.42 | 0.03 | 0.092 | <0.001 | 0.784 |
T3, ng/mL | 0.83 | 0.80 | 0.09 | 0.564 | <0.001 | 0.918 |
T4, ng/mL | 61.43 | 60.68 | 2.52 | 0.836 | <0.001 | 0.308 |
GH, ng/mL | 4.06 | 4.32 | 0.22 | 0.418 | <0.001 | 0.499 |
IGF-1, ng/mL | 162.30 | 167.70 | 9.73 | 0.428 | <0.001 | 0.635 |
IgA, g/L | 0.72 | 0.73 | 0.12 | 0.694 | <0.001 | 0.301 |
IgG, g/L | 10.13 | 10.47 | 1.19 | 0.214 | 0.015 | 0.989 |
IgM, g/L | 2.36 | 2.49 | 0.09 | 0.121 | 0.007 | 0.107 |
1CON = untreated control; GG = treated with 1 × 1010 cfu/d Lactobacillus rhamnosus GG suspension.
2TP = total protein; BHBA =β-hydroxybutyric; T3 = triiodothyronine; T4 = tetraiodothyronine; GH = growth hormone; IGF-1 = insulin-like growth factor 1; IgA/M/G = immunoglobulin A/M/G.